- $1.07bn
- $1.36bn
- $441.33m
NYSE ORDER IMBALANCE 53324.0 SHARES ON BUY SIDE
Brief: Elizabeth Hoff Joins Artivion Board Of Directors
U.S. RESEARCH ROUNDUP-Charter Communications, Guild Holdings, Waste Management
Brief: Juniper Investment Company Reports 5.2% Stake In Artivion Common Stock, As Of September 23, 2022 - SEC Filing
Artivion slumps on halting trial of heart valve with different drug
Brief: Artivion Follows Recommendation To Stop Proact Xa Clinical Trial
NYSE ORDER IMBALANCE 72619.0 SHARES ON BUY SIDE
Brief: Artivion Reports Second Quarter 2022 Financial Results
Brief: Artivion Initiates Enrollment In Persevere Clinical Trial
NYSE ORDER IMBALANCE 73240.0 SHARES ON SELL SIDE
Artivion Inc reports results for the quarter ended in March - Earnings Summary
Artivion Inc expected to post a loss of 12 cents a share - Earnings Preview
Artivion Inc reports results for the quarter ended in December - Earnings Summary
Artivion Inc expected to post a loss of 6 cents a share - Earnings Preview